[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO330968B1 - Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre - Google Patents

Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre

Info

Publication number
NO330968B1
NO330968B1 NO20050883A NO20050883A NO330968B1 NO 330968 B1 NO330968 B1 NO 330968B1 NO 20050883 A NO20050883 A NO 20050883A NO 20050883 A NO20050883 A NO 20050883A NO 330968 B1 NO330968 B1 NO 330968B1
Authority
NO
Norway
Prior art keywords
synthesis
addition salts
ivabradine
pharmaceutically acceptable
acceptable acid
Prior art date
Application number
NO20050883A
Other languages
English (en)
Other versions
NO20050883L (no
NO20050883D0 (no
Inventor
Jean-Pierre Lecouve
Daniel Brigot
Isaac Gonzalez Blanco
Jean-Michel Lerestif
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20050883D0 publication Critical patent/NO20050883D0/no
Publication of NO20050883L publication Critical patent/NO20050883L/no
Publication of NO330968B1 publication Critical patent/NO330968B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Fremgangsmåte for syntesen av forbindelsen med formel (I): Anvendelse i syntesen av ivabradin, addisjonssalter derav med en farmasøytisk akseptabel syre, og hydrater derav.
NO20050883A 2004-05-19 2005-02-18 Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre NO330968B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0405453A FR2870537A1 (fr) 2004-05-19 2004-05-19 Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (3)

Publication Number Publication Date
NO20050883D0 NO20050883D0 (no) 2005-02-18
NO20050883L NO20050883L (no) 2005-11-21
NO330968B1 true NO330968B1 (no) 2011-08-29

Family

ID=34941962

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050883A NO330968B1 (no) 2004-05-19 2005-02-18 Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre

Country Status (33)

Country Link
US (1) US6982350B2 (no)
EP (1) EP1598333B1 (no)
JP (1) JP4148952B2 (no)
KR (1) KR100649289B1 (no)
CN (1) CN1332933C (no)
AR (1) AR047746A1 (no)
AT (1) ATE342885T1 (no)
AU (1) AU2005200883B2 (no)
BR (1) BRPI0500480B8 (no)
CA (1) CA2496708C (no)
CY (1) CY1105826T1 (no)
DE (1) DE602005000187T2 (no)
DK (1) DK1598333T3 (no)
EA (1) EA007746B1 (no)
EG (1) EG23719A (no)
ES (1) ES2275258T3 (no)
FR (1) FR2870537A1 (no)
GE (1) GEP20074135B (no)
HK (1) HK1081945A1 (no)
HR (1) HRP20060449T3 (no)
MA (1) MA27640A1 (no)
ME (1) ME01395B (no)
MX (1) MXPA05005139A (no)
MY (1) MY139475A (no)
NO (1) NO330968B1 (no)
NZ (1) NZ538329A (no)
PL (1) PL1598333T3 (no)
PT (1) PT1598333E (no)
RS (1) RS50512B (no)
SI (1) SI1598333T1 (no)
UA (1) UA79482C2 (no)
WO (1) WO2005123659A1 (no)
ZA (1) ZA200501469B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE544754T1 (de) * 2006-11-30 2012-02-15 Cadila Healthcare Ltd Verfahren zur herstellung von ivabradinhydrochlorid
KR101478855B1 (ko) 2007-05-30 2015-01-02 인드-스위프트 래버러토리즈 리미티드 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법
CN101434552B (zh) * 2007-11-16 2012-05-23 江苏恒瑞医药股份有限公司 4,5-二甲氧基-1-(甲基氨基甲基)-苯并环丁烷的拆分
FR2927900B1 (fr) * 2008-02-27 2010-09-17 Clariant Specialty Fine Chem Procede de preparation d'alpha-aminoacetals optiquement actifs.
FR2933975B1 (fr) * 2008-07-17 2011-02-18 Servier Lab Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
CN101671265B (zh) * 2008-09-12 2012-08-15 中国科学院上海药物研究所 一种苯并环丁烷类化合物及其制备方法与用途
ES2402765T3 (es) * 2008-12-22 2013-05-08 Krka, D.D., Novo Mesto Procedimiento de preparación de ivabradina
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2943668B1 (fr) 2009-03-31 2011-05-06 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
ME00987B (me) * 2009-03-31 2012-06-20 Servier Lab Novi postupak sinteze ivabradina i njegovih soli sa farmaceutski prihvatljivom kiselinom
EA201290772A1 (ru) 2010-02-12 2013-02-28 КРКА, д.д., НОВО МЕСТО Новые формы ивабрадина гидрохлорида
HUP1000245A2 (en) 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
CN102249937A (zh) * 2010-05-18 2011-11-23 上海京新生物医药有限公司 1-(s)-4,5-二甲氧基-1-甲胺基甲基-苯并环丁烷的制备方法
CN102372642B (zh) * 2011-07-04 2014-01-08 江苏宇田生物医药科技有限公司 (1s)-4,5-二甲氧基-1-[(甲基氨基)甲基]苯并环丁烷的制备方法
ITMI20111467A1 (it) 2011-08-01 2013-02-02 Laboratorio Chimico Int Spa Procedimento per la preparazione di ivabradina e di suoi intermedi di sintesi
CN102408346B (zh) * 2011-10-31 2014-07-02 江苏阿尔法药业有限公司 一种4,5-二甲氧基-1-（甲基氨基甲基）-苯并环丁烷的制备方法
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2986804A1 (fr) 2012-02-09 2013-08-16 Servier Lab Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique ou de ses esters, et application a la synthese de l'ivabradine et de ses sels
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2993561B1 (fr) 2012-07-17 2014-10-31 Servier Lab Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"
FR3005658B1 (fr) * 2013-05-17 2015-04-24 Servier Lab "procede de synthese du 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable"
WO2015022702A2 (en) * 2013-08-10 2015-02-19 Ind-Swift Laboratories Limited Process for preparation of 4,5-dimethoxybenzene derivatives and use in the synthesis of ivabradine and salts thereof
CN103524360B (zh) * 2013-10-17 2015-09-30 安徽安腾药业有限责任公司 一种伊伐布雷定关键中间体的合成方法
KR20160110517A (ko) * 2014-02-06 2016-09-21 우베 고산 가부시키가이샤 인돌린 화합물의 제조 방법
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN110483312A (zh) * 2019-08-27 2019-11-22 北京阳光诺和药物研究有限公司 一种高纯度盐酸伊伐布雷定及其中间体的制备方法
CN115286577B (zh) * 2022-08-25 2023-10-20 江苏永安制药有限公司 一种盐酸伊伐布雷定及其中间体的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3263531D1 (en) * 1981-08-05 1985-06-20 Fisons Plc Amine derivatives, processes for their production and pharmaceutical compositions containing them
JP2823679B2 (ja) * 1990-05-08 1998-11-11 東レ株式会社 光学活性２―メチルピペラジンの製造方法
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
JPH083120A (ja) 1994-06-21 1996-01-09 Ajinomoto Co Inc アシル−アミノ酸とα−アリールアミンとの付加塩及びα−アリールアミンの光学分割法
JPH09208546A (ja) * 1995-11-29 1997-08-12 Ajinomoto Co Inc 新規置換ベンジルアミンの付加塩及びその光学分割法

Also Published As

Publication number Publication date
US6982350B2 (en) 2006-01-03
BRPI0500480B8 (pt) 2021-05-25
DE602005000187D1 (de) 2006-11-30
HRP20060449T3 (en) 2007-03-31
EP1598333A1 (fr) 2005-11-23
FR2870537A1 (fr) 2005-11-25
ME01395B (me) 2010-03-02
EA200500239A1 (ru) 2005-12-29
PT1598333E (pt) 2007-01-31
MY139475A (en) 2009-10-30
AR047746A1 (es) 2006-02-15
PL1598333T3 (pl) 2006-12-29
CA2496708A1 (fr) 2005-11-19
CY1105826T1 (el) 2011-02-02
NZ538329A (en) 2005-10-28
HK1081945A1 (en) 2006-05-26
JP4148952B2 (ja) 2008-09-10
ATE342885T1 (de) 2006-11-15
CN1699331A (zh) 2005-11-23
KR100649289B1 (ko) 2006-11-24
RS50512B (sr) 2010-03-02
MXPA05005139A (es) 2005-11-24
CA2496708C (fr) 2011-03-15
WO2005123659A1 (fr) 2005-12-29
DK1598333T3 (da) 2007-02-12
EG23719A (en) 2007-06-17
ES2275258T3 (es) 2007-06-01
ZA200501469B (en) 2005-11-30
KR20060042118A (ko) 2006-05-12
NO20050883L (no) 2005-11-21
UA79482C2 (en) 2007-06-25
BRPI0500480B1 (pt) 2020-08-11
GEP20074135B (en) 2007-06-25
EP1598333B1 (fr) 2006-10-18
BRPI0500480A (pt) 2006-06-06
EA007746B1 (ru) 2006-12-29
DE602005000187T2 (de) 2007-09-06
CN1332933C (zh) 2007-08-22
MA27640A1 (fr) 2005-12-01
SI1598333T1 (sl) 2007-02-28
NO20050883D0 (no) 2005-02-18
JP2005330263A (ja) 2005-12-02
US20050261376A1 (en) 2005-11-24
AU2005200883B2 (en) 2010-07-15
AU2005200883A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
NO330968B1 (no) Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
MY141194A (en) Process for the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
MX2008016423A (es) Arilamidas sustituidas con tetrazol.
TW200732303A (en) Novel fused pyrrole derivatives
JO2807B1 (en) A new process for the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acid.
SG158026A1 (en) New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2- one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
RS51146B (sr) Novi difenil-azetidinon sa poboljšanim fiziološkim osobinama postupak za njegovu proizvodnju,lekovi koji sadrže ovo jedinjenje i njihova upotreba
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
GB0212410D0 (en) Organic compounds
NO20055257L (no) Ny fremgangsmate for syntesen av s-indolin-2-karboksylsyre og anvendelse derav i syntesen av perindopril
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY136638A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MX2009003106A (es) Nueva modificacion cristalina de 4-(n-metil-2-cloro-5-piridilmetil amino)-2,5-dihidrofuran-2-ona.
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY149837A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
UA80905C2 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
JO2518B1 (en) A new method for the combination of ivabradine and its added salts with pharmaceutically acceptable acid